Podcasts about clinical practice

Dr. Peter Addy, LPC, LMHC, integrates foundational set and setting concepts with core therapeutic competencies to support clinicians working with clients who use psychedelics while outlining ethical responses, harm reduction strategies, and ways to incorporate these experiences into ongoing treatment. Interview with Elizabeth Irias. Earn CE credit for listening to this episode by joining our low-cost membership for unlimited podcast CE credits for an entire year, with some of the strongest CE approvals in the country (APA, NBCC, ASWB, and more). Learn, grow, and shine with Clearly Clinical Continuing Ed by visiting https://ClearlyClinical.com.

This week, we look at new research on potassium optimization in patients with defibrillators, reducing antihypertensive therapy in nursing homes, an mRNA influenza vaccine, and belzutifan for rare neuroendocrine tumors. We review long QT syndrome and present a case of abnormal behavior and seizures in a young man. We also explore perspectives on primary care reform, tobacco cessation in HIV and tuberculosis care, corporate control in health care, and the simple power of compassion with ice cream.

This honest and reflective episode takes listeners inside the therapy room—where clinical learnings, vulnerability, and growth unfold in real time. Ms Catherine McGrath (Clinical Team Lead and Senior Psychologist) sharea hard-earned lessons from working with OCD clients using ERP (Exposure and Response Prevention), and open up about the emotional toll, missed opportunities, and the courage it takes to keep learning.From the power of self-compassion to the importance of holding space and involving parents in the therapeutic process, this conversation is a valuable reminder that clinicians don't need to be perfect to be effective—they just need to keep showing up.

Send us a textIn this episode of The Incubator Podcast, Ben and Daphna sit down with Dr. Alex Kemper, Division Chief of Primary Care Pediatrics at Nationwide Children's Hospital and Editor-in-Chief of Pediatrics. Dr. Kemper served as chair of the American Academy of Pediatrics subcommittee that authored the 2022 revision of the neonatal hyperbilirubinemia guidelines.Together, they explore the motivations behind revisiting the 2004 guideline, the major changes introduced, and how these revisions are shaping clinical care. Dr. Kemper explains why treatment thresholds for phototherapy were raised, the careful balance between avoiding unnecessary interventions and preventing kernicterus, and the rationale for moving away from the risk stratification nomogram. The discussion highlights phototherapy as an effective but not benign therapy—one that can disrupt bonding, prolong hospitalization, and create family stress when overused.Listeners will gain insight into the complexities of evidence review, the challenges of consensus-building over eight years of work, and the importance of shared decision-making and reliable follow-up after discharge. This conversation not only demystifies the new guidelines but also reframes the way clinicians think about jaundice management, risk stratification, and the broader impact on families.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Episode 322 hosts Dr Mustafa Narwan (Plastic Surgeon from Germany & UAE) This is the fifth of several episodes recorded at ICCE (International Cosmetic Congress and Exhibition) in Cairo, Egypt. Dr Jake and David were honoured to be invited to the event in September 2025 and in doing so, IA became the first podcast in the world to be resident at an aesthetic conference.  In Chapter 5 of these episodes we explore the concepts of biohacking and integrating a holistic approach to patients. Mustafa shares his insights on combining different treatments to cater to individual patient needs, the significance of thorough consultations, and the role of lifestyle modifications like exercise, diet, and sleep in preparing for and recovering from surgery.  00:00 Introduction 00:17 Podcast Purpose and Disclaimer  01:03 Introducing Dr. Mustafa Narwan 01:45 Mustafa's Background and Clinics 02:27 Holistic Medicine Explained 05:34 Consultation Process and Patient Care 11:30 The Importance of Biohacking 13:32 Daily Health Routine and Habits 21:33 Understanding Your Body's Needs 22:18 Dealing with Jet Lag 24:00 Patreon and Community Engagement 25:19 Supplement Regimen for Health and Longevity 29:42 Integrating Biohacking into Clinical Practice 31:09 Controversial Peptides and Scientific Backing 33:25 Common Misconceptions in Aesthetic Treatments 34:34 Personal Insights and Future Goals 36:00 Concluding Thoughts and Farewell JOIN OUR ONLINE COMMUNITY FOR EDUCATION & NETWORKING OPPORTUNITIES CLICK HERE TO BROWSE OUR IA OFFERS FOR DISCOUNTS & SPECIALS CLICK HERE IF YOU'RE A BRAND OR COMPANY & WANT TO WORK WITH US CLICK HERE TO APPLY TO BE A GUEST ON OUR PODCAST CONTACT US

In this episode, we look at new trials on deferring arterial catheterization in shock, beta-blocker use after myocardial infarction, and a treatment for triple-negative breast cancer. We review acromegaly. A case describes a man with dyspnea, edema, and pacemaker lead displacement. We explore perspectives on the burdens of primary care, the erosion of harm reduction, child health policy, and the meaning of hospice.

Joshua Barocas is an associate professor of medicine at the University of Colorado Anschutz Medical Campus. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.A. Barocas. The Erosion of Harm Reduction. N Engl J Med 2025;393:1865-1867. B.A. Barsky, A. Caplan-Bricker, and C. Robertson. Religious Liberty as a Shield for Public Health — The Case of Overdose-Prevention Centers. N Engl J Med 2025;393:1867-1869.

Welcome to the Plant Cunning Podcast! Today, we are thrilled to chat with Richard Mandelbaum, an herbalist, teacher, writer and one of the founders of ArborVitae School of Traditional Herbalism (https://www.arborvitaeny.com/). You can find him at https://www.richardmandelbaum.com/. In this episode, Richard shares his journey into the world of plants and herbalism, his experiences studying botany, and his insights into clinical herbalism. We delve into the importance of slowing down and truly observing the plants around us, the nuances of plant energetics, and the value of crossing scientific and traditional herbalist knowledge. Richard also talks about the dynamics of teaching field botany, working with clients, and the recent exploration of mosses.00:00 Introduction to the Plant Cunning Podcast00:31 Guest Introduction: Richard Mandelbaum00:53 The Herbal Community and Mutual Aid03:27 Richard's Journey to the Plant Path12:14 Learning and Teaching Field Botany27:21 Challenges in Plant Identification30:03 Working with Hawthorne in Herbal Practice36:22 Understanding Herbal Energetics38:13 Discovering Herbalism and Integrating Science38:43 The Value of Multiple Perspectives in Medicine40:41 Astrology and Energetic Systems41:59 Clinical Practice and Herbal Formulation45:53 Challenges in Mainstream Medicine51:44 The Importance of Clinical Experience01:00:28 Reflections on Field Botany01:09:17 Current Practice and Teaching01:13:04 Final Thoughts and Upcoming Events

Want to share your feedback? Send us a message!Dr. Shahriar SheikhBahaei, Assistant Professor of Neurobiology and Behavior at Stony Brook University, joins host Sara MacIntyre, M.A., CCC-SLP, to discuss emerging research exploring the cellular and neurobiological mechanisms underlying stuttering. Dr. SheikhBahaei shares his journey from lived experience with stuttering to leading a neuroscience research lab investigating how glial cells, particularly astrocytes, contribute to motor control and speech-related circuits.The conversation delves into several recent studies from his lab that utilize mouse models to uncover how alterations in astrocyte function and iron regulation may relate to the neural pathways involved in stuttering. Dr. SheikhBahaei walks listeners through the background, scientific rationale, and key findings of these studies, highlighting what they reveal about the non-vocal motor aspects of stuttering and how this basic science may inform future directions in understanding and treatment.The episode concludes with reflections on bridging laboratory research with the lived experiences of people who stutter and fostering collaboration among scientists, clinicians, and the stuttering community.Resources discussed:SheikhBahaei, S., et al. (2025). Non-vocal motor deficits in a transgenic mouse model linked to stuttering disorders. bioRxiv. https://www.biorxiv.org/content/10.1101/2025.08.08.669441v2SheikhBahaei, S., et al. (2025). Iron dysregulation in mice engineered with a mutation associated with stuttering. bioRxiv. https://www.biorxiv.org/content/10.1101/2025.07.30.667752v1SheikhBahaei, S., et al. (2024). Scientists, society, and stuttering: A multi-stakeholder approach. International Journal of Clinical Practice. https://onlinelibrary.wiley.com/doi/full/10.1111/ijcp.13678Shahriar SheikhBahaei, Ph.D., is a neuroscientist and faculty member at Stony Brook University. His research focuses on how the brain controls complex motor behaviors such as speech and breathing, particularly focusing on the role of astrocytes in neural circuits. Growing up with stuttering has influenced his lifelong pursuit to understand the neurobiology of speech and communication. He completed his Ph.D. in Neuroscience through a joint program at University College London and the National Institutes of Health (NIH). He later became one of the first Independent Research Scholars at NIH, where he established his own lab. At Stony Brook University, he continues to investigate the cellular and circuit foundations of speech disorders while also mentoring the next generation of scientists and advocating for more inclusive perspectives on communication.

Overview: In this episode, Dr Joel Gallant gives a history of antiretroviral therapy and HIV drug resistance, drawing on his personal and professional experience beginning in the early 1980s. The views expressed are those of the panelist and not necessarily Gilead Sciences, Inc. The information provided in this podcast is not intended to be and should not be understood to provide medical advice. Listeners should note that our discussions in this episode are relevant to the USA only and may not be appropriate for other regions. This episode was recorded in August 2023 and the content reflects the information available at that time. Guest: Joel Gallant, MD, MPH    For more information, please visit: https://www.pri-med.com/clinical-resources/curriculum/hiv-in-focus    References AIDSVu.org. New HIV diagnoses. 2023. Available from: https://aidsvu.org/local-data/united-states/south/ (Accessed May 19, 2025) AIDSVu.org was developed by the Rollins School of Public Health at Emory University in partnership with Gilead Sciences, Inc. Alonso A, de Irala J. Strategies in HIV prevention: the A-B-C approach. Lancet 2004;364:1033. Available from: https://doi.org/10.1016/s0140-6736(04)17050-5 Bacheler L, Jeffrey S, Hanna G et al. Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy. J Virol 2001;75:4999–5008. Available from: https://doi.org/10.1128/jvi.75.11.4999-5008.2001 Barré-Sinoussi F, Chermann JC, Rey F et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983;220:868–71. Available from: https://doi.org/10.1126/science.6189183 Bayer R, Edington C. HIV testing, human rights, and global AIDS policy: exceptionalism and its discontents. J Health Polit Policy Law 2009;34:301–23. Available from: https://doi.org/10.1215/03616878-2009-002 Centers for Disease Control and Prevention. Pneumocystis pneumonia – Los Angeles. MMWR Morb Mortal Wkly Rep 1981;30:250-2. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/june_5.htm Centers for Disease Control and Prevention. Preventing HIV. 2024. Available from: https://www.cdc.gov/hiv/prevention/index.html (Accessed May 22, 2025) Cohen MS, Chen YQ, McCauley M et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365:493–505. Available from: https://doi.org/10.1056/NEJMoa1105243 Cuevas JM, Geller R, Garijo R et al. Extremely high mutation rate of HIV-1 in vivo. PLoS Biol 2015;13:e1002251. Available from: https://doi.org/10.1371/journal.pbio.1002251 Department of Health and Human Services. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. 2024. Available from: https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/optimizing-antiretroviral-therapy (Accessed May 19, 2025) Dragovic G. Acute pancreatitis in HIV/AIDS patients: an issue of concern. Asian Pac J Trop Biomed 2013;3:422–425. Available from: https://doi.org/10.1016%2FS2221-1691(13)60091-X Eron JJ, Benoit SL, Jemsek J et al. Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party. N Engl J Med 1995;333:1662–9. Available from: https://doi.org/10.1056/nejm199512213332502 Gandhi RT, Tashima KT, Smeaton LM et al. Long-term outcomes in a large randomized trial of HIV-1 salvage therapy: 96-week results of AIDS clinical trials group A5241 (OPTIONS). J Infect Dis 2020;221:1407–15. Available from: https://doi.org/10.1093/infdis/jiz281 Getting to Zero San Francisco. HIV epidemiology annual report 2017. 2022. Available from: https://gettingtozerosf.org/getting-to-zero-resources/hiv-report-2017/ (Accessed May 22, 2025) Global Fund. About the Global Fund. 2024. Available from: https://www.theglobalfund.org/en/about-the-global-fund/ (Accessed May 19, 2025) Gulick RM, Lalezari J, Goodrich J et al. Maraviroc for previously treated patients with R5 HIV-1 infection. N Engl J Med 2008;359:1429–41. Available from: https://doi.org/10.1056/NEJMoa0803152 Gulick RM, Mellors JW, Havlir D et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med 1997;337:734–9. Available from: https://doi.org/10.1056/nejm199709113371102 Haubrich R, Berger D, Chiliade P et al. Week 24 efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients. AIDS 2007;21:F11–8. Available from: https://doi.org/10.1097/QAD.0b013e3280b07b47 HIV Prevention Trials Network. HPTN 052. 2023. Available from: https://www.hptn.org/research/studies/hptn052 (Accessed May 19, 2025) HIV.gov. HIV and AIDS timeline. 2024. Available from: https://www.hiv.gov/hiv-basics/overview/history/hiv-and-aids-timeline/ (Accessed May 19, 2025) HIVinfo.NIH.gov. FDA approval of HIV medicines. 2024. Available from: https://hivinfo.nih.gov/understanding-hiv/infographics/fda-approval-hiv-medicines (Accessed May 19, 2025) i-base. Cross-resistance by drug class. 2025. Available from: https://i-base.info/guides/changing/cross-resistance (Accessed May 19, 2025) Iyidogan P, Anderson KS. Current perspectives on HIV-1 antiretroviral drug resistance. Viruses 2014;6:4095–139. Available from: https://doi.org/10.3390/v6104095 Lalezari JP, Henry K, O'Hearn M et al. Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America. N Engl J Med 2003;348:2175–85. Available from: https://doi.org/10.1056/NEJMoa035026 Landovitz RJ, Donnell D, Clement ME et al. Cabotegravir for HIV prevention in cisgender men and transgender women. N Engl J Med 2021;385:595–608. Available from: https://doi.org/10.1056/NEJMoa2101016 Larder BA, Darby G, Richman DD. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science 1989;243:1731–4. Available from: https://doi.org/10.1126/science.2467383 Lau B, Gange SJ, Moore RD. Risk of non-AIDS-related mortality may exceed risk of AIDS-related mortality among individuals enrolling into care with CD4+ counts greater than 200 cells/mm3. J Acquir Immune Defic Syndr 2007;44:179–87. Available from: https://doi.org/10.1097/01.qai.0000247229.68246.c5 Lucas C. The San Francisco model and the nurses of Ward 5B. Lancet HIV 2019;6:E819. Available from: https://doi.org/10.1016/S2352-3018(19)30267-X Madruga JV, Cahn P, Grinsztejn B et al. Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial. Lancet 2007;370:29–38. Available from: https://doi.org/10.1016/s0140-6736(07)61047-2 Marcelin AG. Resistance to nucleoside reverse transcriptase inhibitors. In: Geretti AM, editor. Antiretroviral Resistance in Clinical Practice. London: Mediscript; 2006. Chapter 1. Available from: https://www.ncbi.nlm.nih.gov/books/NBK2241/ Margolis AM, Heverling H, Pham PA et al. A review of the toxicity of HIV medications. J Med Toxicol 2014;10:26–39. Available from: https://doi.org/10.1007/s13181-013-0325-8 Moore RD, Creagh-Kirk T, Keruly J et al. Long-term safety and efficacy of zidovudine in patients with advanced human immunodeficiency virus disease. Zidovudine Epidemiology Study Group. Arch Intern Med 1991;151:981–6. Available from: https://doi.org/10.1001/archinte.1991.00400050123023 National Institute of Allergy and Infectious Diseases. HIV Undetectable = Untransmittable (U = U), or treatment as prevention. 2019. Available from: https://www.niaid.nih.gov/diseases-conditions/treatment-prevention (Accessed May 19, 2025) Nelson MR, Katlama C, Montaner JS et al. The safety of […] for the treatment of HIV infection in adults: the first 4 years. AIDS 2007;21:1273–81. Available from: https://doi.org/10.1097/QAD.0b013e3280b07b33 New York State Department of Health. Pre-exposure prophylaxis (PrEP) to prevent HIV infection: question and answers. 2012. Available from: https://www.health.ny.gov/publications/0265/ (Accessed May 22, 2025) Overton ET, Richmond G, Rizzardini G et al. Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with human immunodeficiency virus 1 type 1 infection: 152-week results from ATLAS-2M, a randomized, open-label, phase 3b, noninferiority study. Clin Infect Dis 2023;76:1646–54. Available from: https://doi.org/10.1093/cid/ciad020 Pollak EB, Parmar M. Indinavir. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554396/ (Accessed May 19, 2025) Richman DD, Fischl MA, Grieco MH et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med 1987;317:192–7. Available from: https://doi.org/10.1056/nejm198707233170402 Schmit JC, Ruiz L, Clotet B et al. Resistance-related mutations in the HIV-1 protease gene of patients treated for 1 year with the protease inhibitor ritonavir (ABT-538). AIDS 1996;10:995–9. Available from: https://doi.org/10.1097/00002030-199610090-00010 Siliciano JD, Kajdas J, Finzi D et al. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat Med 2003;9:727–8. Available from: https://doi.org/10.1038/nm880 Steigbigel RT, Cooper DA, Kumar PN et al. Raltegravir with optimized background therapy for resistant HIV-1 infection. N Engl J Med 2008;359:339–54. Available from: https://doi.org/10.1056/NEJMoa0708975 TIME. Man of the year. 1996. Available from: https://time.com/vault/issue/1996-12-30/page/1/ (Accessed May 19, 2025) U.S. President's Emergency Plan for AIDS Relief (PEPFAR). About us. 2025. Available from: https://www.state.gov/about-us-pepfar/ (Accessed May 19, 2025)

Anesthesiology 2025 Desiree Chappell and Mike Grocott discuss the latest advancements and key topics in the field of anesthesiology with special guests Sheila Barnett, Chair of the Department of Anesthesiology at Dartmouth Hitchcock Medical Center, Professor of Anesthesiology at Geisel School of Medicine at Dartmouth and Patrick Guffey, Professor of Clinical Practice, Anesthesiology-Pediatric Anesthesiology at the University of Colorado Anschutz Medical Campus. The conversation centers around the Anesthesia Quality Institute (AQI) and its various initiatives, including the National Anesthesia Clinical Outcomes Registry (NACO) and the importance of integrating electronic health records for improved data collection and quality of care. The guests highlight the challenges and opportunities of using clinical data to drive quality improvements and the future potential of collaborating with electronic health record systems like Epic. The episode underscores the importance of quality data in anesthesia and highlights efforts to enhance patient outcomes and healthcare value.

In 1865, German physician and medical writer Justus Hecker published a volume titled The Epidemics of the Middle Ages. In a footnote, he remarked on a strange phenomenon: an outbreak of meowing nuns. In this minisode, I bring you the story of the meowing nuns of late medieval France and the men who told their story.Researched, written, and produced by Corinne Wieben with original music by Purple Planet.SourcesPrimaryAristotle. History of Animals. Translated by d' A. W. Thompson. In Aristotle, Complete Works. Vol. 1, 774–993. Princeton, NJ: Princeton University Press, 1984.Aristotle. Politics. Translated by Ernest Barker. Oxford: Oxford University Press, 1977.Hecker, J. F. C. The Epidemics of the Middle Ages. Translated by B. G. Babington. London: Woodfall, 1844. Zimmerman, J. G. Solitude. Vol. II. London: Dilly, 1798.SecondaryBartholomew, Robert E. Little Green Men, Meowing Nuns and Head-Hunting Panics: A Study of Mass Psychogenic Illness and Social Delusion. London: McFarland, 2001.Bartholomew, Robert E. and Simon Wessely. “Protean Nature of Mass Sociogenic Illness: From Possessed Nuns to Chemical and Biological Terrorism Fears.” British Journal of Psychiatry 180, no. 4 (2002): 300–306.Mercer, Christia. “The Philosophical Roots of Western Misogyny.” Philosophical Topics 46, no. 2 (2018): 183–208.Penso G. Roman Medicine. 3rd ed. Noceto: Essebiemme, 2002.Tasca, Cecilia et al. “Women and Hysteria in the History of Mental Health.” Clinical Practice and Epidemiology in Mental Health 8 (2012): 110-9.Support the showEnchantedPodcast.netBluesky/enchantedpodcast.net

In Episode 262 of the Sports Therapy Association Podcast, host Matt Phillips is joined by guests Aimi Healey-Bracher, Sports Rehab Therapist at Praia Sports Rehab and Lead Therapist at Cardiff City FC Women, and Tristen Attenborough, educator & founder of Move Massage Pro, to discuss: ‘MSK Conferences: How Much Do They Affect Your Clinical Practice?'. Aimi and Tristan share honest experiences from the recent 'STA & Hands-On Hub Conference' in Exmouth, and also Therapy Expo, the UK's largest annual multi-disciplinary event, which is returning to the NEC Birmingham this year on the 26th & 27th of November. They talk about what inspires them, what they implement into every day practice, and how connection, clarity and evidence-informed talks influence their work. They episode considers both the benefits of MSK conferences, such as networking, renewed confidence, exposure to new populations and topics, and the potential drawbacks, including cost, size, and sales-driven stands, and how conferences may best be used as a jumping-off point rather than a step-by-step solution.  Useful Links Aimi Healey-Bracher on Instagram: @praiasportsrehab Aimi Healey-Bracher Website Tristan Attenborough on Instagram: @movemassagepro Tristan Attenborough Website Therapy Expo Website Sports Therapy Association Website   Host Matt Phillips - Speaker at Therapy Expo If you are a clinician who is interested in improving your communication skills, be sure to attend Matt Phillips' presentation at this year's Therapy Expo: '

In this episode, we discuss long-term outcomes after chest-wall irradiation for breast cancer, new treatments for psoriasis and obesity, and early results on a vaccine for Lassa fever. We review opioid deprescribing and a clinical case describes spiraling into a distant past. Perspectives examine the corporatization of health care, the health effects of new energy legislation, and Medicaid cuts affecting U.S. children.

Yashaswini Singh is an assistant professor of health services, policy, and practice at Brown University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. Y. Singh. The Antitrust Antidote to Hospital and Nursing Home Corporatization — Promises and Pitfalls. N Engl J Med 2025;393:1761-1764.

How much do you know about new therapies for treating fibrosis in MASH and the patients who can benefit most from them? Credit available for this activity expires: 10/29/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003068?ecd=bdc_podcast_libsyn_mscpedu

The November 2025 Recall revisits four insightful episodes centered on muscle and neuromuscular diseases. Kicking off the episode is a two-part series on myositis, where Dr. Stacey Clardy speaks with Dr. Andrew Mammen. The episode continues with an interview featuring Dr. Eric Voorn, who discusses the effectiveness of combining personalized, home-based aerobic exercise with coaching to improve physical fitness in individuals with neuromuscular diseases. The episode wraps up with Dr. Elia Sechi discussing the critical role of interpreting lab test results, understanding assay performance, and recognizing the real-world impact of false positives in myasthenia gravis diagnostics.  Podcast links: Updates on All Things Myositis – Part 1  Updates on  All Things Myositis - Part 2 Efficacy of Aerobic Exercise and Coaching on Physical Fitness in Neuromuscular Disease  False Positivity of Acetylcholine Receptor Autoantibodies in Clinical Practice Article links: Efficacy of Combined Aerobic Exercise and Coaching on Physical Fitness in People With Neuromuscular Diseases Risk of False Acetylcholine Receptor Autoantibody Positivity by Radioimmunoprecipitation Assay in Clinical Practice Show citations:  Oorschot S, Brehm MA, van Groenestijn AC, et al. Efficacy of Combined Aerobic Exercise and Coaching on Physical Fitness in People With Neuromuscular Diseases: A Randomized Clinical Trial. Neurology. 2025;105(1):e213781. doi:10.1212/WNL.0000000000213781 Zara P, Chessa P, Deiana GA, et al. Risk of False Acetylcholine Receptor Autoantibody Positivity by Radioimmunoprecipitation Assay in Clinical Practice. Neurology. 2025;104(9):e213498. doi:10.1212/WNL.0000000000213498 Disclosures can be found at Neurology.org.   

The Grayken Center for Addiction at Boston Medical Center's Behind the Evidence podcast is pleased to host "Behind the Masthead," a special series of episodes featuring conversations with addiction journal editors and other scholars on navigating current threats to addiction science and academic freedom. As the primary means of knowledge dissemination in the field, addiction journals are likely to be substantially impacted by the recent drastic changes to the federal funding of medical and public health research in the US. Through conversations with the editors of our field's leading scientific journals—as well as data scientists and other scholars—this series will offer addiction research professionals of all career stages the opportunity to learn valuable strategies for preserving the momentum and integrity of their research.Episode 1 is out now. Guest host Casy Calver, PhD interviews Alex Walley, MD and Emily Williams, PhD—two editors of the Grayken Center's journal, Addiction Science & Clinical Practice.Behind the Evidence is the addiction medicine podcast of the Grayken Center for Addiction at Boston Medical Center, and a project of the Center's free bimonthly newsletter Alcohol, Other Drugs, and Health: Current Evidence (AODH). This special series, “Behind the Masthead,” is guest-hosted by Casy Calver, PhD.Behind the Evidence hosts: Honora L. Englander, MD and Marc R. Larochelle, MDProduction: Raquel Silveira, MBAEditing: Casy Calver, PhDMusic and cover art: Mary Tomanovich, MAMiriam Komaromy, MD is the Executive Director of the Grayken Center for Addiction, and co-Editor-in-Chief of AODH, together with David Fiellin, MDLearn more about AODH and subscribe for free at www.aodhealth.org“Behind the Evidence” is supported by the Grayken Center for Addiction at Boston Medical Center. It is intended for educational purposes only, and should not be considered medical advice. The views expressed here are our own, and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.

The Grayken Center for Addiction at Boston Medical Center's Behind the Evidence podcast is pleased to host "Behind the Masthead," a special series of episodes featuring conversations with addiction journal editors and other scholars on navigating current threats to addiction science and academic freedom. As the primary means of knowledge dissemination in the field, addiction journals are likely to be substantially impacted by the recent drastic changes to the federal funding of medical and public health research in the US. What can we learn from the perspectives of addiction journal editors and other scholars in this moment of uncertainty?In this first episode of the “Behind the Masthead” series, guest host Casy Calver, PhD speaks with Alex Walley, MD and Emily Williams, PhD—two editors of the Grayken Center's journal, Addiction Science & Clinical Practice—on the lessons we can learn from the resilience of people who use drugs, to navigating changes to the NIH's public access policy.Behind the Evidence is the addiction medicine podcast of the Grayken Center for Addiction at Boston Medical Center, and a project of the Center's free bimonthly newsletter Alcohol, Other Drugs, and Health: Current Evidence (AODH). This special series, “Behind the Masthead,” is guest-hosted by Casy Calver, PhD.Behind the Evidence hosts: Honora L. Englander, MD and Marc R. Larochelle, MDProduction: Raquel Silveira, MBAEditing: Casy Calver, PhDMusic and cover art: Mary Tomanovich, MAMiriam Komaromy, MD is the Executive Director of the Grayken Center for Addiction, and co-Editor-in-Chief of AODH, together with David Fiellin, MDLearn more about AODH and subscribe for free at www.aodhealth.org“Behind the Evidence” is supported by the Grayken Center for Addiction at Boston Medical Center. It is intended for educational purposes only, and should not be considered medical advice. The views expressed here are our own, and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.

What if the monsters that haunt us at night aren't supernatural at all, but reflections of our own minds? In this episode of The Aging Well Podcast, Dr. Jeff Armstrong sits down with clinical psychologist Dr. Brian A. Sharpless to explore the fascinating intersection of sleep, anxiety, and fear.With decades of clinical experience, Dr. Sharpless has studied both common and rare sleep disorders—from insomnia and night terrors to the little-known “exploding head syndrome.” Drawing from his book Monsters on the Couch and years of research, he shares how anxiety, trauma, and unresolved inner conflict often shape what keeps us awake at night.Together, they unpack how sleep disturbances affect not just our nights but also our long-term health and aging. You'll also hear why understanding fear and the unconscious mind can help us move toward better sleep, stronger mental health, and ultimately, aging well.Learn more about Dr. Sharpless at https://briansharpless.com/BUY Monsters on the Couch and other books by Dr. Brian A. Sharpless on Amazon and support this podcast:Monsters on the Couch: The Real Psychological Disorders Behind Your Favorite Horror Movies https://amzn.to/4n3yYpjSleep Paralysis: Historical, Psychological, and Medical Perspectives https://amzn.to/41rWYdsUnusual and Rare Psychological Disorders: A Handbook for Clinical Practice and Research https://amzn.to/46beXYdPsychodynamic Therapy Techniques: A Guide to Expressive and Supportive Interventions https://amzn.to/3JvGsTMPlease, support The Aging Well Podcast by hitting the ‘like' button, subscribing/following the podcast, sharing with a friend, and….BUY the products you need to… age well from our trusted affiliates and support the mission of The Aging Well Podcast*.The Aging Well Podcast merchandise | Show how you are aging well | Use the promo code AGING WELL for free shipping on orders over $75 | https://theagingwellpodcast-shop.fourthwall.com/promo/AGINGWELLRebalance Health | products created by hormone health experts to lower cortisol, improve sleep, and minimize the impact of stress on the body and mind | https://get.aspr.app/SH1AkZ or https://rebalancehealth.com with the promo code: AGING WELLAuro Wellness | Glutaryl—Antioxidant spray that delivers high doses of glutathione (“Master Antioxidant”) | 10% off Code: AGINGWELL at https://aurowellness.com/agingwellpodcastBerkeley Life | Optimize nitric oxide levels | Purchase your starter kit at a 15% discount | Use the promo code: AGINGWELL15 | https://berkeleylife.pxf.io/c/6475525/3226696/31118Oxford Healthspan | Primeadine®,a plant-derived spermidine supplement | 10% off code: AGINGWELL | https://oxford-healthspan.myshopify.com/AgingWellJigsaw Health | Trusted supplements. “It's fun to feel good.” | Click the following link for 10% off: https://www.jigsawhealth.com/?rfsn=8710089.1dddcf3&utm_source=refersion&utm_medium=affiliate&utm_campaign=8710089.1dddcf3Prolon | The Fasting Mimicking Diet (FMD) is a revolutionary five-day nutrition program scientifically formulated to mimic the effects of a prolonged water fast while still allowing nourishment - supporting the benefits of fasting without the challenges and risks that come from water-only fasts. | For the best available discount always use this link: ⁠https://prolonlife.com/theagingwellpodcastThrive25—Your personal longevity advisor | https://www.thrive25.com/early-access?via=william-jeffrey Fusionary Formulas | Combining Ayurvedic wisdom with Western science for optimal health support. | 15% off Code: AGINGWELL | https://fusionaryformulas.com?sca_ref=9678325.IHg5xYhdOzzke8ZrDr Lewis Nutrition | Fight neurodegeneration and cognitive decline with Daily Brain Care by Dr Lewis Nutrition—a provendaily formula designed to protect and restore brain function. | 10% off code: AGINGWELL or use the link: https://drlewisnutrition.com/AGINGWELL*We receive commission on these purchases. Thank you.

This week, we look at new findings from the European prostate cancer screening study, advances in lung cancer therapy, physical therapy for meniscal tear, and a promising vaccine for Salmonella Paratyphi A. We review noninvasive liver fibrosis assessment and a complex clinical case, and explore perspectives on concierge care, kidney disease equity, WIC enrollment, community health, FDA regulation, and standing with colleagues in Gaza.

In this episode of SurgOnc Today, the SSO HPB disease site working group reviews strategies for implementation of histothripsy ablation in the management of liver primary and secondary malignancies, including a discussion of the evidence supporting it and support from the IDEAL framework for the adoption of surgical innovations into clinical practice. To do so, Drs. Miral Sadaria Grandhi and Zhi Ven Fong, members of the HPB disease site working group, are joined by Drs. Hop Tran Cao, Brock Hewitt, and Jeffrey Barkun.

Imagine a world where your voice holds the key to early disease detection, where a simple conversation can offer objective insights into your health. Join us as Henry O'Connell shares the inspiring journey of Canary Speech, transforming how clinicians understand and treat a spectrum of conditions.Chapter Summary:00:00 Introducing Henry O'Connell and Canary Speech02:08 The Genesis of Canary Speech06:56 How Canary Speech Technology Works12:05 Impact of Age, Gender, and Multimodal Analysis16:22 Diverse Applications and Real-Time Results20:29 Future Vision and Integration in Healthcare25:50 Addressing Ethical Concerns and Data Security30:08 Clinical Integration and Objective Pain Measurement34:51 The Impact on Clinical Practice and Patient Outcomes39:52 AI's Frontier: Speech, Multimodal Data, and LLMs43:55 Minimizing Errors and Enhancing Diagnostics47:18 Language Adaptability and Early Detection51:04 Remembering Jeff Adams and Contact InformationFeatured Quotes:“I'd always wanted to apply speech and language to the analysis of human condition and disease.” - Henry O'Connell“We could be returning four or five different scores like a blood profile, the voice profile.” - Henry O'Connell“It's helping us be the doctors we were trained to be.” - Henry O'ConnellBehind the Story:Henry O'Connell recounts the 40-year friendship with co-founder Jeff Adams, a pioneer in speech technology, whose vision to apply speech analysis to human health laid the foundation for Canary Speech. From deciphering Cold War spy messages to building Dragon Naturally Speaking and the Amazon Echo, Adams' expertise combined with O'Connell's experience in corporate turnarounds brought their shared dream to life. The company, even named by O'Connell's daughter, now stands at the forefront of medical innovation, using speech to objectively measure indicators of various diseases.Learn more about Canary Speech and their advancements in AI speech technology at www.canaryspeech.com.Connect With Henry O'Connell:Email: henry@canaryspeech.comCanary Speech Website: https://www.canaryspeech.com/Get In Touch!rob@2docstocpodcast.com

This promotional podcast has been initiated and funded by Merck, and a Merck product will be discussed. The intended audience is multiple sclerosis healthcare professionals in the UK only. The comments of the speakers in this podcast reflect their own opinions and are not necessarily those of Merck.

INFINITY Study on the timing of thyroid medication ingestionI have a growth near my eye that is changing in color and becoming crusty. What should I do?I've been suffering from hip pain for the last three years. Any suggestions on what to do?Could toxic exposures like mold cause conditions like low thyroid or autoimmunity?

With a calcium score of zero, is there any fat in your diet?  Are there any recommended supplements for IBS?What is the safest and most appropriate dose of vitamin D3 for most seniors?

During this episode I discuss the difference between entry to practice & clinical practice. I outline both the differences and similarities between the two and what I've learned in each. I hope this reflection helps you on what ever part of the journey you are on, whether you are looking at a career in healthcare or otherwise. This episodes featured Pup is Alba. If you want adopt Alba, or        learn about all the great dogs the Hamilton/Burlington SPCA has up for adoption you can visit https://www.hbspca.shop/products/alba

Send us a textIn this episode of At the Bench, Betsy Crouch and David McCulley engage in a thought-provoking conversation with Dr. Eleanor Molloy, a neonatologist and physician scientist. They explore Eleanor's journey in neonatology, the importance of inflammation in neonatal health, and the challenges and rewards of conducting research in this field. The discussion also highlights the significance of collaboration, both within research teams and with parents, to enhance clinical practice and improve outcomes for neonates. Eleanor shares insights on the role of biomarkers, the impact of sex differences in research, and the necessity of international collaboration in pediatric research. The episode concludes with reflections on the balance between clinical work and research, the importance of community in academia, and the need for a rallying call to inspire the next generation of clinician scientists.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

In this episode, we look at new research on mucoactive therapy for bronchiectasis, aspirin use in anticoagulated patients with coronary disease, and sotatercept for early pulmonary arterial hypertension. We explore the genetics behind misdiagnosed common diseases and review uncertainty in medical training. We also share a case of woman with abdominal distention, edema, and pleural effusions and Perspectives on sickle cell disease, fetal personhood, and living with a genetic diagnosis.

Eberechi Nwogu-Onyemkpa is an assistant professor in the Division of Palliative Medicine at Washington University in St. Louis. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E. Nwogu-Onyemkpa and Others. Involving Palliative Care to Improve Outcomes in Sickle Cell Disease. N Engl J Med 2025;393:1553-1556. E. Costa and Others. Thirty Years of Hydroxyurea for Sickle Cell Anemia — Scientific Progress, Global Health Gaps. N Engl J Med 2025;393:1556-1559.

In this episode, we explore psychedelic-assisted therapy in clinical practice, examining how these treatments differ fundamentally from traditional pharmacotherapy. Can psychiatrists reconcile mystical experiences with evidence-based medicine while navigating the complex therapeutic paradigm of preparation, 8-hour sessions, and integration work? Faculty: Franklin King, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CMEs: Use of Psychedelic Drugs in Psychiatry Psychedelic-Assisted Therapy in Clinical Practice

In this episode, we look at new research in cervical cancer, lupus, gene therapy for immune deficiency, and malaria prevention in infants. We review hair loss in women, follow a case of tuberculosis in advanced HIV, and hear perspectives on vaccines, primary care, digital health, infection surveillance, AI in disaster response, Medicare policy, and bearing witness in conflict zones.

Michael Liu is a resident physician at Brigham and Women's Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. M. Liu, K.T. Kadakia, and R.K. Wadhera. Proliferation of Prior Authorization in Traditional Medicare — None the WISeR? N Engl J Med 2025;393:1457-1459.

Carolyn McMakin, MA, DC - https://frequencyspecific.com     Kim Pittis, LCSP, (PHYS), MT - https://fsmsports365.com 00:22 Welcome to the FSM Podcast 01:27 FSM Advanced 2026 Event Schedule Highlights 06:07 Orthobiologics and FSM 12:20 The Importance of Patient History 19:12 Managing Chronic Pain and Patient Expectations 25:42 Teaching Experiences in Ireland 26:41 Personal Stories and Clinical Practice 27:51 Understanding Patient Perspectives 28:13 Exploring PTSD and Trauma 29:58 Treating Peripheral Neuropathy 35:00 Autoimmune Conditions and Vagus Nerve 46:30 Navigating Complex Patient Cases 52:56 Upcoming Courses and Events **Exploring the Potential of FSM in Chronic Pain Management** In the realm of modern medical practice, managing chronic pain and patient expectations is a multifaceted challenge. Frequency Specific Microcurrent (FSM) emerges as a beacon of hope for practitioners seeking effective alternatives to conventional care. This modality offers innovative solutions for chronic issues, often unresponsive to traditional treatments, and underpins a concerted approach to harnessing the principles of orthobiologics and metabolic pathways. **Orthobiologics and FSM: Enhancing Recovery Outcomes** Orthobiologics has been a game-changer in regenerative medicine, particularly for procedures like Platelet-Rich Plasma (PRP) injections. FSM complements these procedures by offering a tailored approach to pain management and tissue healing. It's crucial to understand that the biologic process involved in healing can be supported by FSM without hindering inflammation, which is a vital part of recovery. Therefore, the application of FSM is strategically customized based on the stage of healing and the patient's specific needs. **Adapting FSM Protocols to Individual Patient Needs** It's important to emphasize that FSM protocols are not one-size-fits-all. Practitioners must assess the stage of healing and tailor FSM settings accordingly. In the context of post-PRP procedures, considerations such as the level of pain and stage of recovery influence protocol selections. Moreover, the intricate mechanisms of action in FSM require practitioners to eliminate certain frequencies, such as those that might suppress necessary inflammatory responses during healing phases. **Engaging with Patient Histories for Enhanced Therapeutic Outcomes** FSM practice thrives on the understanding that patient histories are critical to therapeutic success. Each patient's narrative provides insight into their unique experiences and expectations regarding pain management and recovery. A profound exploration of patient histories allows practitioners to piece together a comprehensive understanding, which is instrumental in tailoring FSM treatments effectively. **Integrating Emotional and Psychosocial Dimensions in Patient Care** The emotional and psychological dimensions of pain are powerful determinants of patient outcomes. Engaging with these aspects can unearth underlying issues contributing to chronic pain. Encouraging patients to envision their lives post-recovery invites a positive mindset and diminishes the psychological fatigue associated with prolonged pain management. Practitioners are urged to facilitate discussions about the patient's life without pain, fostering an environment of hope and possibility. **Educating Patients as Vital Partners in Their Treatment Journey** Ultimately, FSM practitioners should view themselves as educators and facilitators in the healing journey. Effective communication regarding prognosis, realistic outcomes, and the importance of adherence to FSM protocols can empower patients. Providing comprehensive education about their condition and treatment plan helps patients internalize the importance of active participation and compliance, ultimately optimizing their health outcomes.

 Ever wondered if your gut health protocols are truly helping, or possibly harming, your microbiome? Join Lindsey Parsons and Dr. Brad Leech as they unpack the latest science on antimicrobials, microbiome testing, leaky gut, low stomach acid, prebiotics and more. Discover when to use certain interventions, how to protect your beneficial bacteria, and which strategies really make a difference based on the research. Lindsey Parsons, your host, helps clients solve gut issues and reverse autoimmune disease naturally. Take her quiz to see which stool or functional medicine test will help you find out what's wrong. She's a Certified Health Coach at High Desert Health in Tucson, Arizona. She coaches clients locally and nationwide. You can also follow Lindsey on Facebook, Tiktok, X, Instagram or Pinterest or reach her via email at lindsey@highdeserthealthcoaching.com to set up your free 30-minute Gut Healing Breakthrough Session. Show Notes

Linda Nurra, a certified classical homeopath and flower essence practitioner, joins this episode to share her insights into the world of Bach flower remedies. Growing up in Sardinia, she was mentored by a local herbalist whose influence sparked her lifelong curiosity about natural healing. Linda explains how Dr. Edward Bach developed his remedies using simple methods the sun and boiling techniques, to capture the energetic qualities of flowers in full bloom. She breaks down how these gentle, non-toxic remedies can be safely used by anyone, even alongside homeopathy, to support emotional balance and resilience. We also talk about key remedies like Rescue Remedy and Star of Bethlehem, which Linda often recommends for easing shock, stress, and trauma. Episode Highlights: 03:18 - Linda's Introduction to Homeopathy and Bach Flowers 07:42 - How Bach Flower Remedies Are Made  11:35 - Differences Between Homeopathy and Bach Flowers 14:47 - Clinical Practice and Material Medica of Bach Flowers 17:42 - The 38 Bach Flower Remedies 23:16 - Applications and Safety of Bach Flowers 27:56 - How Bach Flowers Work on Mental and Emotional Levels 34:47 - Bach Flowers for Shock and Trauma 43:58 - Bach Flowers for Collective Trauma and Grief 48:11 - Combining and Dosing Bach Flower Remedies 50:54 - Bach Flowers for Personal Growth and Spiritual Practice About my Guests: Linda Nurra is a certified classical homeopath, flower essence practitioner, and educator with a thriving virtual practice based in Santa Barbara, California. A natural teacher at heart, Linda is dedicated to sharing the wisdom of homeopathy and flower essence therapy in ways that inspire, enlighten, and empower others. Her path to healing began nearly three decades ago with an encounter with flower essences, sparking a lifelong exploration of human emotion, consciousness, and the transformative power of nature. This journey eventually led her to homeopathy, where a profound personal experience with a single remedy ignited her full commitment to holistic healing. She went on to earn an advanced practitioner diploma from the School of Homeopathy (UK) and has since trained with leading teachers around the world. With a background in education, curriculum design, and leadership, Linda has served as curriculum director and lead faculty at the Prometheus Homeopathic Institute and has taught at the Los Angeles School of Homeopathy and the Veterinary Homeopathy Institute. She has also published widely and contributed to the homeopathic community as a board member of the California Homeopathic Medical Society. Today, Linda's work focuses on flower essence therapy—a gentle yet powerful complement to homeopathy that supports resilience and self-reliance. She teaches the popular Bach Flower Therapy for Homeopaths certification course, bridging clinical homeopathy with flower essence practice. When she's not teaching or consulting, Linda can be found connecting with the natural world among the oaks, olives, and grapevines of California's Central Coast—her favorite kind of medicine. Find out more about Linda Website: https://www.insighthomeopathy.com/ If you would like to support the Homeopathy Hangout Podcast, please consider making a donation by visiting www.EugenieKruger.com and click the DONATE button at the top of the site. Every donation about $10 will receive a shout-out on a future episode. Join my Homeopathy Hangout Podcast Facebook community here: https://www.facebook.com/groups/HelloHomies Follow me on Instagram https://www.instagram.com/eugeniekrugerhomeopathy/ Here is the link to my free 30-minute Homeopathy@Home online course: https://www.youtube.com/watch?v=vqBUpxO4pZQ&t=438s Upon completion of the course - and if you live in Australia - you can join my Facebook group for free acute advice (you'll need to answer a couple of questions about the course upon request to join): www.facebook.com/groups/eughom

Rahul Banerjee, MD, FACP, Fred Hutchinson Cancer Center, Seattle, WA Recorded on September 25, 2025 Rahul Banerjee, MD, FACP Assistant Professor Fred Hutchinson Cancer Center Seattle, WA In this episode, Dr. Rahul Banerjee from Fred Hutchinson Cancer Center in Seattle, WA, discusses the evolving role of measurable residual disease (MRD) in hematologic malignancies. He explores […]

In this episode, we explore new treatments for hypertension, hereditary amyloidosis, and malaria prevention, along with insights on mosquito-borne disease control. We review idiopathic intracranial hypertension, follow a striking case of a hidden foreign body, and hear perspectives on worker safety, immigrant health care, the role of pharmaceutical wholesalers, and the arc of a medical career.

Andrew Gabrielson is a pediatric urology fellow at Lurie Children's Hospital of Chicago. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A.T. Gabrielson and C. Corwin. Occupational Health and Safety on the Chopping Block — What's at Stake? N Engl J Med 2025;393:1353-1355.

Alex McDonald, MD, speaks with Robert H. Hopkins, Jr., MD, about how physicians can navigate discussions about vaccines.

In today's episode of To Birth and Beyond, Anita answers the question that might be on your mind as a practitioner: do I need to have given birth to work with pregnant and postpartum populations? The short answer: NOPE! Tune in to hear Anita discuss why she started to work with the perinatal population prior to having her own kids, advice she received (and mindset shifts she made), and why she is grateful to have niched down as she did!- - - - - - - - -If you liked this episode of To Birth and Beyond, tell your friends! Find us on iTunes and Spotify to rate/review/subscribe to the show.Want more? Visit www.ToBirthAndBeyond.com, join our Facebook group (To Birth and Beyond Podcast), and follow us on Instagram @tobirthandbeyondpodcast! Thanks for listening and joining the conversation!Resources and References Anita's course: Birth Prep for Clinical PracticeEpisode 411: Thinking About Adding Pelvic Floor Health as an Ortho Physiotherapist? I'll Help You DecideFor information about mentorship coaching calls with Anita – email support@anitalambert.com or DM @holistichealthphysio on InstagramShow Notes 0:55 - Anita shares what she is talking about today, and offers a bit of a reframe of perspective as we enter the conversation3:05 - Anita explains what her focus was prior to pelvic health, and how she pivoted to a perinatal focus7:24 - Anita dives into client goals and their overlaps in other areas of focus/niches9:22 - Anita shares two things that will help your confidence and competency in perinatal work if you haven't personally given birth11:08 - If you are thinking of diving into perinatal care, Anita shares about her Birth Prep for Clinical Practice course14:02 - Regardless of what clients come to you for, Anita shares that they are ACTUALLY coming to you for…16:46 - Anita urges us to focus on the positives, and what clients CAN do18:30 - Anita suggest what to do if you are considering working with the perinatal population, and why she is so passionate about working with them!21:52 - Anita brings the episode to a close

In this energizing episode, Charity Bryan and Sandra Sims welcome Dr. Julie Kennel, Professor of Clinical Practice at the Ohio State University. With a career spanning clinical nutrition, behavior change research, and academic leadership, Dr. Kennel discusses what drives people's food choices, the power of experiential learning, and the future of personalized nutrition. From mentoring students to leading graduate programs and national organizations, her insights will inform, inspire, and ignite new ideas for nutrition and health professionals alike. Don't miss this rich conversation and of course, a few rapid-fire questions to keep things fun.Interested in our National Summit? Visit our website to learn more: nahpl.org

Neurofibromatosis (NF) and Schwannomatosis can involve skin changes, hearing loss, vision issues, and nerve tumors, but may go unrecognized for years. Neuro-oncologists Katie Metrock, M.D., and Rebecca Brown, M.D., discuss how these two distinct genetic conditions are classified, how they typically present, and how newly approved MEK inhibitors are shaping treatment.

In this episode, Jeff Greenwald—world champion tennis player, licensed therapist, and sports psychology consultant—offers a rare glimpse into the intersection of clinical therapy and high-performance coaching. Jeff highlights how anxiety has become the predominant struggle both inside and outside of sport, often crippling athletes and families alike. Drawing on nearly three decades of experience, he explains how his dual training allows him to work not only on performance enhancement but also on the deeper roots of anxiety, perfectionism, and family dynamics that shape an athlete's experience. He shares how he integrates Cognitive Behavioral Therapy (CBT), Acceptance and Commitment Therapy (ACT), Motivational Interviewing, and Somatic Psychotherapy, tailoring each to the unique needs of athletes. Jeff clarifies how sports psychology typically focuses on attention control, motivation, and performance skills, while clinical practice digs into family systems, emotional regulation, and underlying anxiety. Listeners will also hear about Jeff's practical frameworks, including the four dimensions of focus (narrow/broad, internal/external) and his “remote control” metaphor from The Mental Edge for Young Athletes. These models help young athletes understand they have multiple tools at their disposal—but it's their responsibility to choose and apply them in the heat of competition. A major theme of the conversation is Jeff's emphasis on the “permission to miss.” With statistics showing that 70% of kids quit sports by age 16, Jeff underscores the importance of helping athletes reframe mistakes, embrace imperfection, and cultivate a mastery mindset focused on growth and process rather than outcome. Over time, athletes learn to anchor their confidence in the skills they can control—their routines, effort, and perspective—rather than in outcomes they can't. This framework not only reduces anxiety but also fosters resilience, freedom, and joy in sport. He also shares how parents can best support their children—not by rushing in to fix, but by validating their experiences and normalizing their anxiety. As a competitive athlete himself, and still competing internationally, Jeff has demonstrated how you can transform from a tentative, perfectionistic mindset to a full realization of your ability through the mastery mindset, which also catapulted him to world No. 1 in his age group. He shares how this breakthrough was instrumental to his work and how grateful he is to be in a position to help the thousands of athletes he has worked with over the past 27 years. Jeff Greenwald, MFT, is a world champion athlete, licensed psychotherapist, best-selling author, and one of the world's leading mental coaches for athletes. With over 25 years of experience helping youth, college, and professional competitors thrive under pressure, Jeff brings a rare blend of elite performance insight and clinical expertise to his work. He is the author of the international bestseller The Best Tennis of Your Life, which has sold over 80,000 copies worldwide, and the new book The Mental Edge for Young Athletes—a groundbreaking guide for building confidence, emotional resilience, and a stronger mindset in sports and life. Jeff has worked with athletes across every major sport and consulted for national teams, Fortune 500 leaders, top junior academies, and competitive athletes at all levels of sport. He is a two-time ITF World Champion and was inducted into the Northern California Tennis Hall of Fame in 2019 for his contribution in the field of sports psychology and success as a world-ranked tennis player. Through his writing, coaching, and speaking, Jeff empowers athletes and their families to navigate the mental game with clarity, courage, and lasting confidence.

[Part 3] Review Of The Plant-Based Nutrition And Lifestyle Medicine News August 2025 Part 3 of the August review of lifestyle strategy news and studies for mental health, interventions to prevent cognitive decline, omega-3 fats, the huge benefits of physical activity, UPFs and thumbs up to eating potatoes. Learn more in today's episode, part 3 of 3, written by Dr. Shireen Kassam at Plant Based Health Professionals UK #vegan #plantbased #plantbasedbriefing #wfpb #plantbasednutrition #lifestylemedicine #dietandmentalhealth #hypertension #cognitivedecline  ========================== Original post: https://plantbasedhealthprofessionals.com/review-of-the-plant-based-nutrition-and-lifestyle-medicine-news-august-2025  ========================== RELATED EPISODES: Use search field at PlantBasedBriefing.com/episodes  ========================== Plant-Based Health Professionals UK is an non-profit organization dedicated to providing education and advocacy on whole food plant-based nutrition and lifestyle medicine for prevention and treatment of chronic disease. In addition to practicing conventional medicine, they promote health and well-being using a plant-based lifestyle approach. They reaize there is no doubt that conventional medicine has resulted in some astonishing advances in patient care. However, the current model of healthcare in the UK focuses primarily on treating established disease, rather than emphasising interventions that could prevent or reduce the burden of chronic disease. They provide a valuable resource for the education of healthcare professionals and the general public alike and aim to empower individuals to take control of their own health. Dr. Shireen Kassam founded PBHP UK in 2018. She's a certified lifestyle medicine physician and author of the book, Eating Plant-Based, Scientific Answers to Your Nutrition Questions, co-authored with her sister Zahra, was published in January 2022. She has also co-edited the textbook Plant-Based Nutrition in Clinical Practice, published in September 2022. Learn more at https://plantbasedhealthprofessionals.com/  ============================== FOLLOW PLANT BASED BRIEFING ON: YouTube: https://www.youtube.com/@plantbasedbriefing     Spotify: https://open.spotify.com/show/2GONW0q2EDJMzqhuwuxdCF?si=2a20c247461d4ad7 Apple Podcasts: https://podcasts.apple.com/us/podcast/plant-based-briefing/id1562925866 Your podcast app of choice: https://pod.link/1562925866 Facebook: https://www.facebook.com/PlantBasedBriefing   LinkedIn: https://www.linkedin.com/company/plant-based-briefing/   Instagram: https://www.instagram.com/plantbasedbriefing/     

In this episode, we explore the evolving role of surrogate endpoints in the management of IgA nephropathy (IgAN), with a particular focus on the significance of estimated glomerular filtration rate (eGFR). Of the completed Phase 3 trials in IgAN, one used time-weighted average eGFR, an area under the curve-based measure that reflects the average change in eGFR from baseline over a specified period, in this case, over the full 2-year study period. The other trial used total eGFR slope to describe the overall rate of change over 2 years. But what do these endpoints mean outside the setting of a clinical trial? Expert insights shed light on how proteinuria and eGFR trends can inform prognosis and guide treatment decisions in clinical practice over the long term. Listeners will gain a deeper understanding of how to interpret eGFR changes over time and apply this knowledge to optimize patient care. Designed for nephrology professionals, this episode offers practical, evidence-based perspectives on integrating these surrogate endpoints into the care of patients with IgAN. Supported by Calliditas Therapeutics Upon completion of the podcast, please take a moment to complete a brief survey: https://kidneyforms.tfaforms.net/4728109

[Part 2] Review Of The Plant-Based Nutrition And Lifestyle Medicine News August 2025 Part 2 of the August review of lifestyle strategy news and studies for mental health, interventions to prevent cognitive decline, omega-3 fats, the huge benefits of physical activity, UPFs and thumbs up to eating potatoes. Learn more in today's episode, part 2 of 3, written by Dr. Shireen Kassam at Plant Based Health Professionals UK #vegan #plantbased #plantbasedbriefing #wfpb #plantbasednutrition #lifestylemedicine #dietandmentalhealth #hypertension #cognitivedecline ========================== Original post: https://plantbasedhealthprofessionals.com/review-of-the-plant-based-nutrition-and-lifestyle-medicine-news-august-2025  ========================== RELATED EPISODES: Use search field at PlantBasedBriefing.com/episodes  ========================== Plant-Based Health Professionals UK is an non-profit organization dedicated to providing education and advocacy on whole food plant-based nutrition and lifestyle medicine for prevention and treatment of chronic disease. In addition to practicing conventional medicine, they promote health and well-being using a plant-based lifestyle approach. They reaize there is no doubt that conventional medicine has resulted in some astonishing advances in patient care. However, the current model of healthcare in the UK focuses primarily on treating established disease, rather than emphasising interventions that could prevent or reduce the burden of chronic disease. They provide a valuable resource for the education of healthcare professionals and the general public alike and aim to empower individuals to take control of their own health. Dr. Shireen Kassam founded PBHP UK in 2018. She's a certified lifestyle medicine physician and author of the book, Eating Plant-Based, Scientific Answers to Your Nutrition Questions, co-authored with her sister Zahra, was published in January 2022. She has also co-edited the textbook Plant-Based Nutrition in Clinical Practice, published in September 2022. Learn more at https://plantbasedhealthprofessionals.com/  ============================== FOLLOW PLANT BASED BRIEFING ON: YouTube: https://www.youtube.com/@plantbasedbriefing     Spotify: https://open.spotify.com/show/2GONW0q2EDJMzqhuwuxdCF?si=2a20c247461d4ad7 Apple Podcasts: https://podcasts.apple.com/us/podcast/plant-based-briefing/id1562925866 Your podcast app of choice: https://pod.link/1562925866 Facebook: https://www.facebook.com/PlantBasedBriefing   LinkedIn: https://www.linkedin.com/company/plant-based-briefing/   Instagram: https://www.instagram.com/plantbasedbriefing/   

Featuring articles on severe acute malnutrition with gastroenteritis in children, medical imaging and pediatric cancer risk, moderate hypertriglyceridemia, preventing RSV disease in healthy infants, and treating hypertension in rural South Africa; a review article on monoclonal gammopathy of undetermined significance; a Clinical Problem-Solving on a shifting frame; and Perspectives on insight into corporate governance, on pharmaceutical tariffs, and on OUD medications.

Steven Lipstein is the former chief executive officer of BJC HealthCare. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S. Lipstein. Insight into Corporate Governance — What Motivates Hospitals and Delivery Systems. N Engl J Med 2025;393:1249-1251.

Featuring articles on heart failure, provoked venous thromboembolism, chronic lymphocytic leukemia, and acute ischemic stroke; a review article on medical education to improve diagnostic equity; a case report of a man with embolic stroke and left ventricular apical aneurysm; two articles on the 2025 Lasker–DeBakey Clinical Medical Research Award; and Perspectives on structural and scientific racism, on the Gates Foundation's final chapter, and on Dr. Kolhouse and the cowboy.